NEPHROS, INC. (NEPH)

Every figure this model derived for NEPH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 4,697,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 13,596,000 AssetsCurrent 2026-06-30
current liabilities 3,344,000 LiabilitiesCurrent 2026-06-30
equity 11,968,000 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2026-06-30
interest expense 1,000 InterestExpenseNonoperating 2025-12-31
ocf -661,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 20,722,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 270,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NEPH on one particular measure came for.

RatioValue
cash operating margin9.83
current ratio4.07
current ratio reported4.07
deferred revenue growth0.0
dilution pct3.46
ebit yoy22.81
fcf margin-3.19
growth cv0.97
interest cover1642.0
operating margin7.92
owner earnings margin-4.49
revenue growth24.2
revenue growth per share20.05
roic17.81
rule of 4032.13
sbc pct revenue1.3

What to be careful about

What this model itself distrusts about NEPH's figures. Written by the derivation as it ran, not added afterwards.